Cargando…
Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patient...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440318/ https://www.ncbi.nlm.nih.gov/pubmed/34536418 http://dx.doi.org/10.1016/j.jaci.2021.09.008 |
_version_ | 1783752685844955136 |
---|---|
author | Hou, Hongyan Zhang, Yandi Tang, Guoxing Luo, Ying Liu, Wei Cheng, Chang Jiang, Yuhuan Xiong, Zhigang Wu, Shiji Sun, Ziyong Xu, Shabei Fan, Xionglin Wang, Feng |
author_facet | Hou, Hongyan Zhang, Yandi Tang, Guoxing Luo, Ying Liu, Wei Cheng, Chang Jiang, Yuhuan Xiong, Zhigang Wu, Shiji Sun, Ziyong Xu, Shabei Fan, Xionglin Wang, Feng |
author_sort | Hou, Hongyan |
collection | PubMed |
description | BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patients with longer follow-up time. METHODS: SARS-CoV-2–specific humoral and cellular responses were assessed in convalescent patients with coronavirus disease 2019 (COVID-19) at 1 year postinfection. RESULTS: A total of 78 convalescent patients with COVID-19 (26 moderate, 43 severe, and 9 critical) were recruited after 1 year of recovery. The positive rates of both anti–receptor-binding domain and antinucleocapsid antibodies were 100%, whereas we did not observe a statistical difference in antibody levels among different severity groups. Accordingly, the prevalence of neutralizing antibodies (nAbs) reached 93.59% in convalescent patients. Although nAb titers displayed an increasing trend in convalescent patients with increased severity, the difference failed to achieve statistical significance. Notably, there was a significant correlation between nAb titers and anti–receptor-binding domain levels. Interestingly, SARS-CoV-2–specific T cells could be robustly maintained in convalescent patients, and their number was positively correlated with both nAb titers and anti–receptor-binding domain levels. Amplified SARS-CoV-2–specific CD4(+) T cells mainly produced a single cytokine, accompanying with increased expression of exhaustion markers including PD-1, Tim-3, TIGIT, CTLA-4, and CD39, while the proportion of multifunctional cells was low. CONCLUSIONS: Robust SARS-CoV-2–specific humoral and cellular responses are maintained in convalescent patients with COVID-19 at 1 year postinfection. However, the dysfunction of SARS-CoV-2–specific CD4(+) T cells supports the notion that vaccination is needed in convalescent patients for preventing reinfection. |
format | Online Article Text |
id | pubmed-8440318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84403182021-09-15 Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection Hou, Hongyan Zhang, Yandi Tang, Guoxing Luo, Ying Liu, Wei Cheng, Chang Jiang, Yuhuan Xiong, Zhigang Wu, Shiji Sun, Ziyong Xu, Shabei Fan, Xionglin Wang, Feng J Allergy Clin Immunol Covid-19 BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patients with longer follow-up time. METHODS: SARS-CoV-2–specific humoral and cellular responses were assessed in convalescent patients with coronavirus disease 2019 (COVID-19) at 1 year postinfection. RESULTS: A total of 78 convalescent patients with COVID-19 (26 moderate, 43 severe, and 9 critical) were recruited after 1 year of recovery. The positive rates of both anti–receptor-binding domain and antinucleocapsid antibodies were 100%, whereas we did not observe a statistical difference in antibody levels among different severity groups. Accordingly, the prevalence of neutralizing antibodies (nAbs) reached 93.59% in convalescent patients. Although nAb titers displayed an increasing trend in convalescent patients with increased severity, the difference failed to achieve statistical significance. Notably, there was a significant correlation between nAb titers and anti–receptor-binding domain levels. Interestingly, SARS-CoV-2–specific T cells could be robustly maintained in convalescent patients, and their number was positively correlated with both nAb titers and anti–receptor-binding domain levels. Amplified SARS-CoV-2–specific CD4(+) T cells mainly produced a single cytokine, accompanying with increased expression of exhaustion markers including PD-1, Tim-3, TIGIT, CTLA-4, and CD39, while the proportion of multifunctional cells was low. CONCLUSIONS: Robust SARS-CoV-2–specific humoral and cellular responses are maintained in convalescent patients with COVID-19 at 1 year postinfection. However, the dysfunction of SARS-CoV-2–specific CD4(+) T cells supports the notion that vaccination is needed in convalescent patients for preventing reinfection. The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2021-12 2021-09-15 /pmc/articles/PMC8440318/ /pubmed/34536418 http://dx.doi.org/10.1016/j.jaci.2021.09.008 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid-19 Hou, Hongyan Zhang, Yandi Tang, Guoxing Luo, Ying Liu, Wei Cheng, Chang Jiang, Yuhuan Xiong, Zhigang Wu, Shiji Sun, Ziyong Xu, Shabei Fan, Xionglin Wang, Feng Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title | Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title_full | Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title_fullStr | Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title_full_unstemmed | Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title_short | Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection |
title_sort | immunologic memory to sars-cov-2 in convalescent covid-19 patients at 1 year postinfection |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440318/ https://www.ncbi.nlm.nih.gov/pubmed/34536418 http://dx.doi.org/10.1016/j.jaci.2021.09.008 |
work_keys_str_mv | AT houhongyan immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT zhangyandi immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT tangguoxing immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT luoying immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT liuwei immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT chengchang immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT jiangyuhuan immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT xiongzhigang immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT wushiji immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT sunziyong immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT xushabei immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT fanxionglin immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection AT wangfeng immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection |